Want to see AVTR full AI Analyst Report?
Revenue by Segment
Shows how much each business segment contributes to total revenue, indicating the company’s diversification and which segments are leading growth or facing headwinds.Reporting changes reveal a clear shift: VWR now anchors the top line while BMP is a smaller, higher‑margin growth engine showing improving orders; Lab Solutions has softened but stabilized after mid‑2025. Management says VWR’s organic decline hit a trough in Q1 and BMP should bottom in Q2, and the Revival program (digital, kaizen, capex) targets margin recovery. Near‑term risks—freight and mix pressure, customer prebates and a modest Middle East inflation hit—mean execution and debt reduction are the decisive catalysts for a sustained recovery.
Date | Laboratory Solutions | Bioscience Production | Bioscience & Medtech Products | VWR Distribution & Services |
|---|---|---|---|---|
Jun 30, 2026 | $0.00 | $0.00 | $451.80M | $1.24B |
Mar 31, 2026 | $0.00 | $0.00 | $431.40M | $1.15B |
Dec 31, 2025 | $1.12B | $547.50M | $0.00 | $0.00 |
Sep 30, 2025 | $1.10B | $527.30M | $0.00 | $0.00 |
Jun 30, 2025 | $1.12B | $561.30M | $0.00 | $0.00 |
Mar 31, 2025 | $1.06B | $516.40M | $0.00 | $0.00 |
Dec 31, 2024 | $1.13B | $560.80M | $0.00 | $0.00 |
Sep 30, 2024 | $1.17B | $542.90M | $0.00 | $0.00 |
Jun 30, 2024 | $1.16B | $547.10M | $0.00 | $0.00 |
Mar 31, 2024 | $1.16B | $522.70M | $0.00 | $0.00 |